Estrogen can stimulate the growth of breast cancer cells that have estrogen receptors. This hormone binds to the ER, activating signaling pathways that promote cell division and tumor growth. Hence, reducing estrogen levels or blocking its action is a key strategy in treating ER-positive breast cancer.
